Concurrent Investment Advisors LLC Increases Position in Oracle Corporation (NYSE:ORCL)

Concurrent Investment Advisors LLC lifted its stake in Oracle Corporation (NYSE:ORCL - Free Report) by 14.5% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 114,673 shares of the enterprise software provider's stock after acquiring an additional 14,479 shares during the period. Concurrent Investment Advisors LLC's holdings in Oracle were worth $16,032,000 at the end of the most recent quarter.

Several other hedge funds also recently added to or reduced their stakes in the business. Norges Bank purchased a new stake in Oracle during the 4th quarter valued at about $2,216,314,000. GAMMA Investing LLC grew its stake in Oracle by 15,012.3% during the 1st quarter. GAMMA Investing LLC now owns 4,755,096 shares of the enterprise software provider's stock valued at $664,810,000 after purchasing an additional 4,723,631 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its stake in Oracle by 20.5% during the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 13,825,360 shares of the enterprise software provider's stock valued at $2,303,858,000 after purchasing an additional 2,350,448 shares during the last quarter. Vanguard Group Inc. grew its stake in Oracle by 1.5% during the 4th quarter. Vanguard Group Inc. now owns 157,411,949 shares of the enterprise software provider's stock valued at $26,231,127,000 after purchasing an additional 2,296,069 shares during the last quarter. Finally, Kovitz Investment Group Partners LLC grew its stake in Oracle by 268.4% during the 4th quarter. Kovitz Investment Group Partners LLC now owns 3,077,947 shares of the enterprise software provider's stock valued at $512,909,000 after purchasing an additional 2,242,520 shares during the last quarter. 42.44% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several research firms have weighed in on ORCL. Oppenheimer reiterated an "outperform" rating on shares of Oracle in a research note on Wednesday, June 18th. JPMorgan Chase & Co. lifted their price target on Oracle from $135.00 to $185.00 and gave the company a "neutral" rating in a research report on Thursday, June 12th. Morgan Stanley reissued an "overweight" rating on shares of Oracle in a report on Wednesday, June 18th. CIBC reaffirmed a "buy" rating on shares of Oracle in a research note on Monday, June 9th. Finally, Citigroup reaffirmed an "outperform" rating on shares of Oracle in a report on Thursday, June 12th. Ten equities research analysts have rated the stock with a hold rating, twenty-two have given a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average price target of $204.15.

Insider Transactions at Oracle

In related news, Vice Chairman Jeffrey Henley sold 400,000 shares of Oracle stock in a transaction on Thursday, June 12th. The stock was sold at an average price of $190.42, for a total value of $76,168,000.00. Following the transaction, the insider owned 1,097,576 shares in the company, valued at approximately $209,000,421.92. This trade represents a 26.71% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Naomi O. Seligman sold 2,866 shares of the business's stock in a transaction dated Monday, May 5th. The stock was sold at an average price of $149.53, for a total value of $428,552.98. Following the transaction, the director owned 31,764 shares in the company, valued at approximately $4,749,670.92. This represents a 8.28% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 440,366 shares of company stock worth $83,103,603 over the last ninety days. 42.20% of the stock is owned by insiders.

Oracle Trading Up 3.2%

Oracle stock traded up $7.41 during midday trading on Friday, reaching $237.39. The stock had a trading volume of 18,441,376 shares, compared to its average volume of 10,159,668. Oracle Corporation has a twelve month low of $118.86 and a twelve month high of $237.99. The stock has a market capitalization of $666.79 billion, a PE ratio of 48.83, a price-to-earnings-growth ratio of 3.55 and a beta of 1.39. The company has a debt-to-equity ratio of 4.07, a quick ratio of 0.75 and a current ratio of 0.75. The stock's 50-day simple moving average is $178.14 and its 200 day simple moving average is $164.26.

Oracle (NYSE:ORCL - Get Free Report) last issued its earnings results on Wednesday, June 11th. The enterprise software provider reported $1.70 earnings per share for the quarter, beating analysts' consensus estimates of $1.64 by $0.06. Oracle had a return on equity of 87.34% and a net margin of 21.68%. The firm had revenue of $15.90 billion for the quarter, compared to analysts' expectations of $15.58 billion. During the same quarter last year, the firm earned $1.63 earnings per share. The firm's revenue for the quarter was up 11.3% compared to the same quarter last year. Analysts expect that Oracle Corporation will post 5 EPS for the current year.

Oracle Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, July 24th. Investors of record on Thursday, July 10th will be issued a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a yield of 0.84%. The ex-dividend date of this dividend is Thursday, July 10th. Oracle's payout ratio is currently 46.08%.

Oracle Profile

Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.